6-Chloro-2-methyl-1H-pyrrolo[3,2-c]pyridine, 97%, 1g

3-(Dibenzylamino)-2,2-difluoropropanoic acid, 97%, 1g

2-Hydroxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 25g

3-Hydroxy-2-methylbenzoic Acid>98.0%(GC)(T)1g

5-Morpholin-4-yl-1,3,4-oxadiazol-2-ylamine, 95.0%, 250mg

N-(1-benzylpyrrolidin-3-yl)-2,2,2-trifluoroacetamide, 98%, 25g

3-Hydroxy-5-methoxybenzaldehyde, 95.0%, 1g

(2-(2,2,2-Trifluoroethoxy)pyridin-3-yl)boronic acid, 98%, 1g

H-D-Val-OtBu.HCl, 95%, 5g

2-(3-((2-Ethylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

1-(2-Ethoxybenzoyl)piperidin-4-amine hydrochloride, 95%, 500mg

(3S,4R,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol, 95.0%, 500g

Tetrahydrofuran D8, 99.5 at%D, 10 ml, glass packaging